Literature DB >> 24565391

Can Supreme™ laryngeal mask airway be an alternative to endotracheal intubation in laparoscopic surgery?

Meltem Turkay Aydogmus1, Hacer Sebnem Yeltepe Turk2, Sibel Oba2, Oya Unsal2, Sitki Nadir Sinikoglu2.   

Abstract

BACKGROUND AND OBJECTIVES: In laparoscopic surgical procedures, experts recommend tracheal intubation for airway management. Laryngeal mask airway (LMA) can be a good alternative to intubation. In this case series, we aimed to examine the use of the Supreme™ LMA (SLMA) in laparoscopic surgical practice.
METHODS: We planned the study for sixty patients between the ages of 18 and 60, who would undergo laparoscopic surgery. We recorded one, 15, 30, 45, and 60-minute peripheral O2 saturation (SpO2) and end-tidal carbon dioxide (EtCO2) values, heart rate and mean arterial blood pressure (MAP). We observed the duration of SLMA insertion, the rate of gastric tube applicability, whether nausea, vomiting, and coughing developed, and whether there was postoperative 1-hour sore throat.
RESULTS: The initial EtCO2 mean was lower than the EtCO2 means of 15, 30, 45, and 60 minutes (p < 0.0001) and the 15-minute EtCO2 mean was lower than other measured EtCO2 means. We observed the initial heart rate mean to be higher than the ones following the SLMA insertion, prior to the SLMA removal, and after the SLMA removal. The heart rate mean after the SLMA insertion was remarkably lower than the heart rate mean prior to the SLMA removal (p=0.013). The MAP after the SLMA insertion was lower than the initial MAP means, as well as the MAP averages prior to after the removal of SLMA (p=0.0001).
CONCLUSION: SLMA can be a suitable alternative to intubation in laparoscopic surgical procedures in a group of selected patients.
Copyright © 2013 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Intratracheal; Intubation; Laparoscopy; Laryngeal Masks

Mesh:

Substances:

Year:  2013        PMID: 24565391     DOI: 10.1016/j.bjane.2012.12.008

Source DB:  PubMed          Journal:  Braz J Anesthesiol


  7 in total

Review 1.  Role of laryngeal mask airway in laparoscopic cholecystectomy.

Authors:  José M Beleña; Ernesto Josué Ochoa; Mónica Núñez; Carlos Gilsanz; Alfonso Vidal
Journal:  World J Gastrointest Surg       Date:  2015-11-27

2.  A clinical trial evaluating the laryngeal mask airway-Supreme in obese children during general anesthesia.

Authors:  Yue Tian; Xiu-Ying Wu; Lu Li; Ling Ma; Yun-Feng Li
Journal:  Arch Med Sci       Date:  2016-12-19       Impact factor: 3.318

3.  Comparison of clinical performance of i-gelⓇ and Baska MaskⓇ during laparoscopic cholecystectomy.

Authors:  So Ron Choi; Tae Young Lee; Sung Wan Kim; Sang Yoong Park; Chan Jong Chung; Jeong Ho Kim
Journal:  Korean J Anesthesiol       Date:  2019-08-20

4.  Can Positive-Pressure Ventilation be Administered with Laryngeal Mask to Pediatric Patients Undergoing Laparoscopic Inguinal Hernia Operation?

Authors:  Hacer Sebnem Turk; Pinar Sayin; Leyla Kilinc; Melih Akin; Abdullah Yildiz; Sibel Oba
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-03-17

5.  Comparison of LMA Supreme, i-gel, and Baska Mask for Airway Management during Laparoscopic Cholecystectomy: A Prospective Randomized Comparative Study from North India.

Authors:  Parul Sharma; Sujeet Rai; Manoj Tripathi; Deepak Malviya; Sumita Kumari; Smarika Mishra
Journal:  Anesth Essays Res       Date:  2022-06-14

6.  Comparison of i-gel® and LMA Supreme® during laparoscopic cholecystectomy.

Authors:  Sang Yoong Park; Jong Cheol Rim; Hyuk Kim; Ji Hyeon Lee; Chan Jong Chung
Journal:  Korean J Anesthesiol       Date:  2015-09-30

7.  Combined use of transversus abdominis plane block and laryngeal mask airway during implementing ERAS programs for patients with primary liver cancer: a randomized controlled trial.

Authors:  Hai-Ming Huang; Rui-Xia Chen; Lin-Mei Zhu; Wen-Shuai Zhao; Xi-Jiu Ye; Jian-Wei Luo; Fu-Ding Lu; Lei Zhang; Xue-Ying Yang; Yuan Yuan; Jun Cao
Journal:  Sci Rep       Date:  2020-09-10       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.